Mostrando entradas con la etiqueta Farmacoseguridad Extrínseca. Mostrar todas las entradas
Mostrando entradas con la etiqueta Farmacoseguridad Extrínseca. Mostrar todas las entradas

A bibliometric analysis of the global research landscape on artificial intelligence applications in clinical medicine (2010–2025)

Strengthening pharmacovigilance through patient reporting: a scoping review of awareness, barriers, and facilitators

A causal machine learning framework for pharmacovigilance signal detection in electronic health records: Drug-induced acute kidney injury

Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia

Too stressed to cope? A multiple mediation analysis of social bonds, sleep quality, and sleep disturbances in relation to prescription drug use among Chinese high school seniors

Pharmacists want action on fake weight-loss jabs

AI-augmented pharmacovigilance for cardio-oncology: FDR- controlled disproportionality and anomaly detection of antineoplastic-associated cardiac events in FAERS (2015 Q1–2025 Q4)

Ensuring patient rights, safety, and welfare in “compassionate use” of drugs

The evolution of ethical and legal regulations of drug research

Barriers to Adverse Drug Reaction Reporting Among Physicians, Nurses, and Pharmacists: A Scoping Review Comparing High-Income Versus Low-/Middle-Income Countries

Early Evaluation of the Food and Drug Administration (FDA) Adverse Event Monitoring System (AEMS): An Analysis of Over 32 Million Pharmacovigilance Reports

Putting FAERS data into perspective: cautionary considerations for comparative safety assessment

Development of a European Union Time-Indexed Reference Dataset for Assessing the Performance of Signal Detection Methods in Pharmacovigilance using a Large Language Model